Login Register Cart 0
Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

Correlations between Overexpression of SOX2OT Long Non-coding RNA and Susceptibility to Breast Cancer

Author(s): Mina Dehghani-Samani, Naiemeh Hassanzadeh, Hamidreza Kabiri, Marzieh Jafari, Matineh Rahmani G. Shahrokhi, Maryam J. Chermahini, Arvand Akbari, Esmat Noshadi, Esmaeil Mahmoudi* and Amela Jusic*

Volume 23, Issue 9, 2020

Page: [981 - 987] Pages: 7

DOI: 10.2174/1386207323666200514075042

Price: $65

Abstract

Background and Objective: The SOX2OT lcnRNA has been recognized as a positive regulator in the transcription regulation of the SOX2 gene. Recent studies have approved the dysregulation of SOX2OT lncRNA expression patterns in some common cancer types, including esophageal, lung, and breast cancer. The objective of the present study was to investigate the correlation between overexpression of SOX2OT lcnRNA and susceptibility to breast cancer.

Methods: SOX2OT lncRNA expression profiling in 15 breast cancer and normal tumour-adjacent breast tissue samples was performed by using qRT-PCR. To evaluate the diagnostic potential of the SOX2OT lncRNA, we performed ROC curve analyses.

Results: The expression of SOX2OT lncRNA in patients suffering from breast cancer revealed a significant overexpression in comparison with the healthy group (P<0.001). Significantly, the elevated circulating SOX2OT lncRNA was found specific to breast cancer and could differentiate breast cancer from controls with 100% of both sensitivity and specificity. Based on the Kaplan- Meier analysis, there was no significant correlation between SOX2OT lcnRNA expression and overall survival.

Conclusion: The results confirmed the association between breast cancer and higher SOX2OT lncRNA expression. According to the ROC curve results, SOX2OT lcnRNA could be a new measurable indicator of the breast cancer and a potential therapeutic target for breast cancer patients.

Keywords: Breast cancer, lcnRNA, SOX2OT, qRT-PCR, cancer, overexpression of SOX2OT.

« Previous
[1]
Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin., 2018, 68(1), 7-30.
[http://dx.doi.org/10.3322/caac.21442] [PMID: 29313949]
[2]
Cauchi, J.P.; Camilleri, L.; Scerri, C. Environmental and lifestyle risk factors of breast cancer in Malta-a retrospective case-control study. EPMA J., 2016, 7, 20.
[http://dx.doi.org/10.1186/s13167-016-0069-z] [PMID: 27679672]
[3]
Rafiemanesh, H.; Salehiniya, H.; Lotfi, Z. Breast cancer in Iranian woman: incidence by age group, morphology and trends. Asian Pac. J. Cancer Prev., 2016, 17(3), 1393-1397.
[http://dx.doi.org/10.7314/APJCP.2016.17.3.1393] [PMID: 27039778]
[4]
Rodríguez Bautista, R.; Ortega Gómez, A.; Hidalgo Miranda, A.; Zentella Dehesa, A.; Villarreal-Garza, C.; Ávila-Moreno, F.; Arrieta, O. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer. Clin. Epigenetics, 2018, 10, 88.
[http://dx.doi.org/10.1186/s13148-018-0514-z] [PMID: 29983835]
[5]
Fang, Y.; Fullwood, M.J. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics Proteomics Bioinformatics, 2016, 14(1), 42-54.
[http://dx.doi.org/10.1016/j.gpb.2015.09.006] [PMID: 26883671]
[6]
Jiang, L.; Bi, D.; Ding, H.; Wu, X.; Zhu, R.; Zeng, J.; Yang, X.; Kan, X. Systematic identification and evolution analysis of Sox genes in Coturnix japonica based on comparative genomics. Genes (Basel), 2019, 10(4), E314.
[http://dx.doi.org/10.3390/genes10040314] [PMID: 31013663]
[7]
Chen, Y.; Shi, L.; Zhang, L.; Li, R.; Liang, J.; Yu, W.; Sun, L.; Yang, X.; Wang, Y.; Zhang, Y.; Shang, Y. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J. Biol. Chem., 2008, 283(26), 17969-17978.
[http://dx.doi.org/10.1074/jbc.M802917200] [PMID: 18456656]
[8]
Askarian-Amiri, M.E.; Seyfoddin, V.; Smart, C.E.; Wang, J.; Kim, J.E.; Hansji, H.; Baguley, B.C.; Finlay, G.J.; Leung, E.Y. Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer. PLoS One, 2014, 9(7), e102140.
[http://dx.doi.org/10.1371/journal.pone.0102140] [PMID: 25006803]
[9]
Shahryari, A.; Jazi, M.S.; Samaei, N.M.; Mowla, S.J. Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis. Front. Genet., 2015, 6, 196.
[http://dx.doi.org/10.3389/fgene.2015.00196] [PMID: 26136768]
[10]
Aguilar-Medina, M.; Avendaño-Félix, M.; Lizárraga-Verdugo, E.; Bermúdez, M.; Romero-Quintana, J.G.; Ramos-Payan, R.; Ruíz-García, E.; López-Camarillo, C. SOX9 stem-cell factor: clinical and functional relevance in cancer. J. Oncol., 2019, 2019, 6754040.
[http://dx.doi.org/10.1155/2019/6754040] [PMID: 31057614]
[11]
Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C(T)). Method. Methods, 2001, 25(4), 402-408.
[http://dx.doi.org/10.1006/meth.2001.1262] [PMID: 11846609]
[12]
Kuhnle, P.J.; Israel, K.F.; Menges, M. Real-life data on improvement of survival after perioperative chemotherapy versus surgery alone on resectable adenocarcinoma of the stomach - a single-center study. Z. Gastroenterol., 2019, 57(5), 606-610.
[http://dx.doi.org/10.1055/a-0841-3513] [PMID: 31083749]
[13]
Derrien, T.; Johnson, R.; Bussotti, G.; Tanzer, A.; Djebali, S.; Tilgner, H.; Guernec, G.; Martin, D.; Merkel, A.; Knowles, D.G.; Lagarde, J.; Veeravalli, L.; Ruan, X.; Ruan, Y.; Lassmann, T.; Carninci, P.; Brown, J.B.; Lipovich, L.; Gonzalez, J.M.; Thomas, M.; Davis, C.A.; Shiekhattar, R.; Gingeras, T.R.; Hubbard, T.J.; Notredame, C.; Harrow, J.; Guigó, R. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res., 2012, 22(9), 1775-1789.
[http://dx.doi.org/10.1101/gr.132159.111] [PMID: 22955988]
[14]
Domenici, G.; Aurrekoetxea-Rodríguez, I.; Simões, B.M.; Rábano, M.; Lee, S.Y.; Millán, J.S.; Comaills, V.; Oliemuller, E.; López-Ruiz, J.A.; Zabalza, I.; Howard, B.A.; Kypta, R.M.; Vivanco, M.D.A.A. Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells. Oncogene, 2019, 38(17), 3151-3169.
[http://dx.doi.org/10.1038/s41388-018-0656-7] [PMID: 30622340]
[15]
Emadian Saravi, O.; Naghshvar, F.; Torabizadeh, Z.; Sheidaei, S. Immunohistochemical expression of nanog and its relation with clinicopathologic characteristics in breast ductal carcinoma. Iran. Biomed. J., 2019, 23, 184-189.
[16]
Jiang, M.C.; Ni, J.J.; Cui, W.Y.; Wang, B.Y.; Zhuo, W. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am. J. Cancer Res., 2019, 9(7), 1354-1366.
[PMID: 31392074]
[17]
Shahryari, A.; Rafiee, M.R.; Fouani, Y.; Oliae, N.A.; Samaei, N.M.; Shafiee, M.; Semnani, S.; Vasei, M.; Mowla, S.J. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma. Stem Cells, 2014, 32(1), 126-134.
[http://dx.doi.org/10.1002/stem.1542] [PMID: 24105929]
[18]
Shi, X-M.; Teng, F. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Int. J. Clin. Exp. Pathol., 2015, 8(4), 4008-4014.
[PMID: 26097588]
[19]
Zhang, Y.; Yang, R.; Lian, J.; Xu, H. LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer. Am. J. Transl. Res., 2016, 8(11), 5035-5043.
[PMID: 27904704]
[20]
Hou, Z.; Zhao, W.; Zhou, J.; Shen, L.; Zhan, P.; Xu, C.; Chang, C.; Bi, H.; Zou, J.; Yao, X.; Huang, R.; Yu, L.; Yan, J. A long noncoding RNA Sox2ot regulates lung cancer cell proliferation and is a prognostic indicator of poor survival. Int. J. Biochem. Cell Biol., 2014, 53, 380-388.
[http://dx.doi.org/10.1016/j.biocel.2014.06.004] [PMID: 24927902]
[21]
Iranpour, M.; Soudyab, M.; Geranpayeh, L.; Mirfakhraie, R.; Azargashb, E.; Movafagh, A.; Ghafouri-Fard, S. Expression analysis of four long noncoding RNAs in breast cancer. Tumour Biol., 2016, 37(3), 2933-2940.
[http://dx.doi.org/10.1007/s13277-015-4135-2] [PMID: 26409453]
[22]
Saghaeian Jazi, M.; Samaei, N.M.; Ghanei, M.; Shadmehr, M.B.; Mowla, S.J. Identification of new SOX2OT transcript variants highly expressed in human cancer cell lines and down regulated in stem cell differentiation. Mol. Biol. Rep., 2016, 43(2), 65-72.
[http://dx.doi.org/10.1007/s11033-015-3939-x] [PMID: 26703382]

Rights & Permissions Print Cite
Article Metrics
13
1
© 2024 Bentham Science Publishers | Privacy Policy